Choosing between ticagrelor and clopidogrel following percutaneous coronary intervention: A systematic review and Meta-Analysis (2007–2017)
Conclusion:
Ticagrelor and clopidogrel were comparable in terms of efficacy in these patients with ACS. However, the safety outcomes of ticagrelor should further be investigated.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Systematic Review and Meta-Analysis Source Type: research
More News: Angioplasty | Bleeding | Clopidogrel | Coronary Angioplasty | Databases & Libraries | Heart Attack | Percutaneous Coronary Intervention | Plavix | Stroke | Study | Thrombosis